Flevox Cat
Active substance
ATC code
Species
Cat
Indications
In cats:
Treatment of flea (Ctenocephalides spp.) and tick (Rhipicephalus sanguineus) infestations.
Insecticidal efficacy against new infestations with adult fleas persists for up to 4 weeks. Newly arriving fleas are killed within 48 hours of landing on the animal. The product can be used as part of a treatment strategy for flea allergy dermatitis (FAD) where this has previously been diagnosed by a veterinary surgeon.
The product has a persistent acaricidal efficacy for up to 1 week against ticks (Rhipicephalus sanguineus and Dermacentor reticulatus). If ticks of Dermacentor reticulatus are present when the product is applied, all the ticks may not be killed within the first 48 hours, but they may be killed within a week.
Dose to be administered and administration route
For external use only.
Spot-on use.
Animals should be weighed accurately prior to treatment.
Apply topically to the skin 1 pipette of 0.5 ml per cat.
The minimum treatment interval is 4 weeks.
Method of Administration:
Part the coat between the shoulder blades until the skin is visible. Place the tip of the pipette on the skin and squeeze gently to empty its content onto the skin.
It is important to make sure that the product is applied to an area where the animal cannot lick it off, and to make sure that animals do not lick each other following treatment.
Care should be taken to avoid excessive wetting of the hair with the product since this will cause a sticky appearance of hairs at the treatment spot. However, should this occur, it will generally disappear within 24 hours post application but can persist for up to 2 weeks.
Adverse reactions
If licking occurs, a brief period of hypersalivation may be observed due mainly to the nature of the carrier.
Among the extremely rare suspected adverse reactions, transient cutaneous reactions at the application site (scaling, local alopecia, pruritus, erythema) and general pruritus or alopecia could occur after use. Exceptionally, hypersalivation, reversible neurological signs (hyperaesthesia, depression, nervous signs), vomiting or respiratory signs could be observed after use.
The frequency of adverse reactions is defined using the following convention:
- very common (more than 1 in 10 animals displaying adverse reaction(s) during the course of one treatment)
- common (more than 1 but less than 10 animals in 100 animals)
- uncommon (more than 1 but less than 10 animals in 1,000 animals)
- rare (more than 1 but less than 10 animals in 10,000 animals)
- very rare (less than 1 animal in 10,000 animals, including isolated reports).
PRICE | Only for registered vets. Create a free profile to access all features.. Login |
---|---|
Art. Nr. | |
EAN | 3605874254237 |